Global impact of tobacco control policies on smokeless tobacco use: a systematic review protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
24 12 2020
Historique:
entrez: 28 12 2020
pubmed: 29 12 2020
medline: 15 5 2021
Statut: epublish

Résumé

Smokeless tobacco (ST) was consumed by 356 million people globally in 2017. Recent evidence shows that ST consumption is responsible for an estimated 652 494 all-cause deaths across the globe annually. The WHO Framework Convention on Tobacco Control (FCTC) was negotiated in 2003 and ratified in 2005 to implement effective tobacco control measures. While the policy measures enacted through various tobacco control laws have been effective in reducing the incidence and prevalence of smoking, the impact of ST-related policies (within WHO FCTC and beyond) on ST use is under-researched and not collated. A systematic review will be conducted to collate all available ST-related policies implemented across various countries and assess their impact on ST use. The following databases will be searched: Medline, EMBASE, PsycINFO, Cumulative Index to Nursing and Allied Health Literature, Scopus, EconLit, ISI Web of Science, Cochrane Library (CENTRAL), African Index Medicus, LILACS, Scientific Electronic Library Online, Index Medicus for the Eastern Mediterranean Region, Index Medicus for South-East Asia Region, Western Pacific Region Index Medicus and WHO Library Database, as well as Google search engine and country-specific government websites. All ST-related policy documents (FCTC and non-FCTC) will be included. Results will be limited to literature published since 2005 in English and regional languages (Bengali, Hindi and Urdu). Two reviewers will independently employ two-stage screening to determine inclusion. The Effective Public Health Practice Project's 'Quality Assessment Tool for Quantitative Studies' will be used to record ratings of quality and risk of bias among studies selected for inclusion. Data will be extracted using a standardised form. Meta-analysis and narrative synthesis will be used. Permission for ethics exemption of the review was obtained from the Centre for Chronic Disease Control's Institutional Ethics Committee, India (CCDC_IEC_06_2020; dated 16 April 2020). The results will be disseminated through publications in a peer-reviewed journal and will be presented in national and international conferences. CRD42020191946.

Identifiants

pubmed: 33361080
pii: bmjopen-2020-042860
doi: 10.1136/bmjopen-2020-042860
pmc: PMC7768955
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e042860

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Monika Arora (M)

HRIDAY, New Delhi, India.
Health Promotion Division, Public Health Foundation of India, Gurugram, Haryana, India.

Neha Jain (N)

Health Promotion Division, Public Health Foundation of India, Gurugram, Haryana, India.

Masuma Mishu (M)

Department of Health Sciences, University of York, York, UK.

Melanie Boeckmann (M)

School of Public Health, Bielefeld University, Bielefeld, Germany boeckmannmelanie@gmail.com.

Suranji Dahanayake (S)

Department of Health Sciences, University of York, York, UK.
Ministry of Health, Nutrition and Indigenous Medicine, Colombo, Sri Lanka.

Jappe Eckhardt (J)

Department of Politics, University of York, York, UK.

Sarah Forberger (S)

Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.

Rumana Huque (R)

University of Dhaka, Dhaka, Bangladesh.

Mona Kanaan (M)

Department of Health Sciences, University of York, York, UK.

Zohaib Khan (Z)

Khyber Medical University, Peshawar, Pakistan.

Ravi Mehrotra (R)

Indian Council of Medical Research, India Cancer Research Consortium, New Delhi, India.

Muhammad Aziz Rahman (MA)

School of Health, Federation University Australia, Berwick, Victoria, Australia.
La Trobe University, Melbourne, Victoria, Australia.

Anne Readshaw (A)

Department of Health Sciences, University of York, York, UK.

Aziz Sheikh (A)

Usher Institute, University of Edinburgh, Edinburgh, UK.

Kamran Siddiqi (K)

Department of Health Sciences, University of York, York, UK.

Aishwarya Vidyasagaran (A)

Department of Health Sciences, University of York, York, UK.

Omara Dogar (O)

Department of Health Sciences, University of York, York, UK.
Usher Institute, University of Edinburgh, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH